Product Information

AMLODIPINE-BENAZEPRIL 5-20 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1036 per EA under NDC 68180045901. Its NADAC has been published 395 times since Jan 30, 2019.

FDA first approved this application on Feb 5, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-BENAZEPRIL 5-20 MG

Amlodipine Besylate and Benazepril Hydrochloride
$0.1036per EA

Strength

5; 20 mg/1; mg/1

NDC

68180045901

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078466

FDA Approved

2/5/2010

TE Code

AB

On Market Since

8/1/2018

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Decreased Blood Pressure
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-BENAZEPRIL 5-20 MG has been published 395 times since Jan 30, 2019, and over the history we have for it it has declined 17.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1036 per EA
All-time high$0.1458 (Apr 15, 2020)
All-time low$0.0887 (Nov 20, 2024)
52-week high$0.1103
52-week low$0.1036
Median price$0.1252
Average price$0.1228
Largest weekly change-24.5% (Nov 20, 2024)
Weeks tracked395
Tracking sinceJan 30, 2019

Price History

1W

-0.5%

1M

-0.5%

3M

-1.7%

6M

-2.3%

1Y

-5.1%

3Y

-22.5%

5Y

-21.1%

All

-17.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-BENAZEPRIL 5-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 5-20 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.1036 per EA (NDC 68180045901), effective Aug 19, 2026.

How has the price of AMLODIPINE-BENAZEPRIL 5-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 5-20 MG has declined 17.6%. It has been tracked across 395 weekly CMS publications since Jan 30, 2019.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 5-20 MG?

Since Jan 30, 2019, the NADAC for AMLODIPINE-BENAZEPRIL 5-20 MG has ranged from a low of $0.0887 (Nov 20, 2024) to a high of $0.1458 (Apr 15, 2020), with a median of $0.1252 per EA.

Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 5-20 MG?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-BENAZEPRIL 5-20 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-BENAZEPRIL 5-20 MG?

AMLODIPINE-BENAZEPRIL 5-20 MG (NDC 68180045901) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.